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Abstract
Background and Aims: Sporadic colorectal cancer (CRC) development is a sequential process showing age-dependency,
uncontrolled epithelial proliferation and decreased apoptosis. During juvenile growth cellular proliferation and apoptosis
are well balanced, which may be perturbed upon aging. Our aim was to correlate proliferative and apoptotic activities in
aging human colonic epithelium and colorectal cancer. We also tested the underlying molecular biology concerning the
proliferation- and apoptosis-regulating gene expression alterations.
Materials and Methods: Colorectal biopsies from healthy children (n1 = 14), healthy adults (n2 = 10), adult adenomas
(n3 = 10) and CRCs (n4 = 10) in adults were tested for Ki-67 immunohistochemistry and TUNEL apoptosis assay. Mitosis- and
apoptosis-related gene expression was also studied in healthy children (n1 = 6), adult (n2 = 41) samples and in CRC (n3 = 34)
in HGU133plus2.0 microarray platform. Measured alterations were confirmed with RT-PCR both on dependent and
independent sample sets (n1 = 6, n2 = 6, n3 = 6).
Results: Mitotic index (MI) was significantly higher (p,0.05) in intact juvenile (MI = 0.3360.06) and CRC samples
(MI = 0.4260.10) compared to healthy adult samples (MI = 0.1560.06). In contrast, apoptotic index (AI) was decreased in
children (0.1360.06) and significantly lower in cancer (0.0660.03) compared to healthy adult samples (0.1760.05). Eight
proliferation- (e.g. MKI67, CCNE1) and 11 apoptosis-associated genes (e.g. TNFSF10, IFI6) had altered mRNA expression both
in the course of normal aging and carcinogenesis, mainly inducing proliferation and reducing apoptosis compared to
healthy adults. Eight proliferation-associated genes including CCND1, CDK1, CDK6 and 26 apoptosis-regulating genes (e.g.
SOCS3) were differently expressed between juvenile and cancer groups mostly supporting the pronounced cell growth in
CRC.
Conclusion: Colorectal samples from children and CRC patients can be characterized by similarly increased proliferative and
decreased apoptotic activities compared to healthy colonic samples from adults. Therefore, cell kinetic alterations during
colorectal cancer development show uncontrolled rejuvenescence as opposed to the controlled cell growth in juvenile
colonic epithelium.
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Introduction
The normal cell renewal of the healthy colonic epithelium
takes about 5 days, through cell proliferation, differentiation
and apoptosis. The location of different types of epithelial cells
in the crypts is very typical. Proliferating cells mostly reside on
the basis of the crypts, differentiated cells in the middle zone,
while the apoptotic cells are close to the luminal surface.
Several molecular pathways play important role in the
physiological self-renewal of epithelial cells in the human large
intestine [1–4].
However, the regulation of proliferative and apoptotic mech-
anisms may alter during normal aging and colorectal carcinogen-
esis. Aging is a physiologic mechanism that begins after
conception. It affects almost every cell in the organism with the
possible exception of stem cells and tumor cells. Macroscopic and
microscopic changes are present in the aging gastrointestinal tract
including the large bowel [5–6]. Changes in proliferative activity
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in the course of aging have been analyzed in animal models in
previous studies [7–8]. According to the results of Mandir et al., the
most intensive epithelial regeneration (proliferation and apoptosis)
has been proven in young rats; and the authors concluded that
dramatic changes in young colonic epithelium can be related to
intestinal development. However, the normal gastrointestinal
aging has no affect on epithelial renewal [7]. On the contrary,
in aged animal populations increased cell proliferation and
decreased apoptosis in colonic epithelium was observed and
thought to facilitate uncontrolled cell proliferation and tumori-
genesis, which might explain the higher incidence of colorectal
cancer in the elderly human [8].
Furthermore, some of these alterations may also be related to
colorectal carcinogenesis. Changes in epithelial cell growth and
programmed cell death were also previously studied in different
stages of colorectal carcinogenesis, but the results are not
concordant. Cell proliferation and apoptosis may become dysreg-
ulated and the unbalanced cell production and cell loss determine
the behavior of premalignant or malignant disorders and tumor
growth [9–12].
The detection rate of adenomas and the incidence of advanced
colorectal adenomas and cancers continually elevate after the age
of 40–50, showing strong age dependency [13–14]. Sporadic colon
cancers turn out mostly in the older adult population similarly to
numerous neoplastic and precancerous lesions. According to the
Vogelstein model [15], colorectal cancer develops from normal
epithelium through pre-malignant adenoma in a multi-step
process which takes several years. Besides the genes (e.g. APC,
KRAS, DCC and TP53) traditionally implicated in this cancer
progression model, recently novel genes with altering mRNA
expression have also been suggested to be contribute to malignant
transformation of colorectal epithelium [16–18].
There are several genetic and epigenetic alterations that can
demonstrate a possible relationship between aging and colorectal
carcinogenesis. Accumulation of DNA mutations and damages,
promoter hypermethylation, alterations in DNA repair, telomerase
activity and cellular metabolism may increasingly affect aged
populations leading to elevated cell proliferation and decreased
apoptosis, which may culminate to malignant transformation and
uncontrolled cell proliferation [19].
At the same time, several human and animal studies have
revealed the opposing regulation of some molecular pathways
during normal aging and carcinogenesis. As opposed to normal
aging, proliferating cancer cells show increased metabolism,
characterized by continuous proliferative activity and de-differen-
tiation, they can produce embryonic proteins and are potentially
immortal by escaping apoptosis [20]. In particular, apoptosis-
regulating proteins show distinct expression in senescent and
cancer cells featured by the downregulation of the apoptosis-
inducing tumor suppressor p53 protein [21] and Fas/CD95
protein [22] and the overexpression of antiapoptotic proto-
oncogene Bcl-2 in cancer as opposed to normal aging cells [23–
25]. Oncogenes such as Ras, transcription factors e.g. Myc, and
growth signal transduction-related tyrosine-kinase receptors e.g.
members of the EGFR family are up-regulated in some cancers,
while downregulated in senescent cells [26–28].
Cancer development can be considered as a local, uncontrolled
‘‘rejuvenation’’ utilizing the same molecular pathways but with
opposing regulation. Deregulated cell proliferation and apoptosis
pathways can allow survival advantages for cancer cells against
adjacent senescent cells, due to lost ability of cancer for normal
aging [20]. Increased epithelial cell proliferation in the gastroin-
testinal tract can be seen not only in colorectal cancer, but also in
embryonic and juvenile development. An essential pathway that
plays fundamental roles both in gut development and in sporadic
or familial colorectal cancers is the Wnt/b-catenin signaling [29–
30].
As we are aware, there is no study focusing on the proliferation
and apoptosis regulation in the juvenile human colorectal
epithelium in relation to normal aging and carcinogenesis. The
purpose of this study was to analyze the proliferative and apoptotic
activity in human colonic epithelium in the course of normal aging
and colorectal carcinogenesis both at protein and gene expression
level. Colorectal biopsies representing the juvenile controlled
growth stage, the adult healthy status and the uncontrolled
colorectal cancer development were tested for potential correla-
tions.
Materials and Methods
Patients and samples
After informed consent, colorectal biopsy samples were taken
during routine endoscopic intervention at the 2nd Department
of Internal Medicine and 1st Department of Paediatrics,
Semmelweis University, Budapest, Hungary. Altogether, 44
tissue samples were analyzed in the immunohistochemical study
(14 healthy children, 10 healthy adults, 10 adenomas from
adults and 10 CRCs from adults); 81 biopsy samples were
analyzed in microarray analysis (6 healthy children, 41 healthy
adults and 34 CRCs from adults); and 36 biopsy samples were
involved in real-time PCR validation (12 healthy children, 12
healthy adults and 12 CRCs from adults). Seventy-five
microarrays (the adult samples) had been hybridized earlier;
their data files were used in a previously published studies using
different comparisons [31–32] and are available in the Gene
Expession Omnibus database (series accession number:
GSE10714 and GSE37364). The datasets of the newly
hybridized 6 microarrays are registered on the GSE37267 serial
accession number. Control children were referred to the
outpatient clinic with rectal bleeding, constipation or chronic
abdominal pain. Ileocolonoscopy was part of their diagnostic
procedure (exclude organic disease) and the biopsy specimens
showed normal macroscopic appearance and histology. Every
specimen was verified by histopathologists.
For immunohistochemistry colorectal biopsy samples were
routinely fixed in formaldehyde and embedded in paraffin wax.
For mRNA studies, colonoscopy samples were stored in
RNALater Reagent (Qiagen Inc, Germantown, US) at 280uC
before total RNA extraction for gene expression analysis and
Taqman RT-PCR study. Ethical approvals (Nr.: 69/2008 and
202/2009) for this study were issued by the Regional and
Institutional Committee of Science and Research Ethics of
Semmelweis University (Budapest, Hungary). Written informed
consent was obtained in advance from all adult participants and
from the next of kin, caretakers, or guardians on the behalf of the
minors/children approved by the ethics committees. Detailed
clinicopathological specification of the patient samples are
summarized in Table 1 and Table 2.
Immunohistochemistry for cell proliferation
Archived samples from 14 histologically normal colonic biopsies
from children, 10 normal colonic biopsies from adults, as well as
10 adult adenomas and 10 CRCs were collected during routine
endoscopy. 1 mm-diameter cores were punched out from paraffin
blocks of adult samples and collected into tissue microarrays
(TMA). Four mm thick sections cut both from the TMAs and from
individual children biopsy samples were dewaxed and rehydrated
for immunostaining.
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After antigen retrieval in a pH 9.0 TRIS-EDTA buffer using a
microwave oven at 900 W for 10 min and then at 370 W for
40 min, blocking of endogenous peroxidases in 1% hydrogen
peroxide dissolved in methanol and of nonspecific binding sites
using 1% bovine serum albumin for 20 min each were performed.
Slides were incubated with mouse monoclonal anti-Ki-67 antibody
(Clone: MIB-1, 1:100, Dako, Glostrup, Denmark) for 60 min in a
humidified chamber and then with anti-mouse IgG F(ab9)2 Alexa
Fluor 546 conjugate (1:200, Invitrogen, Carlsbad, CA, USA) for
30 min.
Apoptosis detection using the Tdt-mediated dUTP Nick
End Labeling (TUNEL) assay
After digestion with proteinase-K (20 mg/ml, 20 min), 50 ml
TUNEL (TUNEL In Situ Cell Death Detection Kit, Fluorescein,
Roche, 11684795910) reaction mixture (5 ml TdT enzyme+45 ml
dUTP) was added to the tissue sections and TMA slides. Then the
samples were incubated in a dark humidified chamber at 37 Cu for
120 minutes. Cell nuclei were stained with Hoechst (5 ml Hoechst
dye+10 ml TBS, 1 min, Sigma-Aldrich, St. Louis, Mo, USA).
Counting of mitotic and apoptotic index in digital slides
Stained biopsy samples and TMA slides were digitalized with a
high resolution digital scanner (Pannoramic Scan, 3DHISTECH
Ltd. Budapest, Hungary) using multilayer fluorescent scanning
with a high numeric aperture (0.8)620 objective lens and a high
dynamic range AxioCam Mrm Rev.3 black-and-white camera
connected to the scanner. Digital slides were accessed through a
computer monitor and analyzed using the Pannoramic Viewer
software (version 1.11.43.0). The Marker Counter software
module resulting in permanent annotations on the counted cells
was used to estimate the relative ratio of proliferative, apoptotic
and normal cells.
Ki-67, TUNEL and Hoechst positivities appeared all as strong
nuclear labeling in the slides. Depending on sample size, 500–1000
epithelial cells were counted in longitudinal well-oriented crypts.
We have determined the proliferative-apoptotic ratio (PAR: ratio
of proliferative and apoptotic cells in crypts), the mitotic index (MI:
the ratio of proliferative cells and total counted cells in crypts) and
the apoptotic index (AI: the ratio of apoptotic cells and total
counted cells in crypts).
mRNA microarray expression analysis
Total RNA was extracted using RNeasy Mini Kit (Qiagen Inc.,
Germantown, USA) according to the manufacturer’s instructions.
Quantity of isolated RNA was characterized by measuring
absorbance (NanoDrop ND-1000 Spectrophotometer, NanoDrop
Technologies, Inc., Wilmington, USA). Quality of isolated RNA
was tested with capillary gel electrophoresis (2100Bioanalyzer and
Table 1. Subgroups of patients participating in immunohistochemistry, microarray analysis and PCR validation with the number of
samples and mean age values.
Number of patients participating in the study
Immunohistochemistry
Group Number of samples (female/male) Mean age ± SD (years)
Children (Ch) 14 (7/7) 11.265.5
Healthy adults (N) 10 (4/6) 60614.2
Adenoma from adults (Ad) 10 (4/6) 66.763.9
CRCs from adults (CRC) 10 (3/7) 68.5614.4
Total patient numbers 44 (18/26)
Affymetrix microarray analysis
Group Number of samples (female/male) Mean age ± SD (years)
Children (Ch) 6 (2/4) 11.265.3
Healthy adults (N) 41 (26/15) 53615.9
CRCs from adults (CRC) 34 (19/15) 68.5610.3
Total patient numbers 81 (47/34)
Taqman RT-PCR validation
Group Number of original samples (female/male) Mean age ± SD (years)
Children (Ch) 6 (2/4) 12.265.3
Healthy adults (N) 6 (3/3) 57.7618.9
CRCs from adults (CRC) 6 (4/2) 6967.0
Total patient numbers 18 (9/9)
Group Number of independent samples (female/male) Mean age ± SD (years)
Children (Ch) 6 (3/3) 5.563.4
Healthy adults (N) 6 (3/3) 53616.9
CRCs from adults (CRC) 6 (1/5) 64.3610.8
Total patient numbers 18 (7/11)
doi:10.1371/journal.pone.0074140.t001
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RNA 6000 Pico Kit/Agilent Inc., Santa Clara, CA, USA/).
Biotinylated cRNA probes were synthesized from 1 to 8 mg total
RNA and fragmented using the One-Cycle Target Labeling and
Control Kit (http://www.affymetrix.com/support/downloads/
manuals/expression_s2_manual.pdf), according to the Affymetrix
description. Twenty micrograms of each fragmented cRNA
sample was hybridized into HGU133 Plus2.0 array (Affymetrix)
at 45uC for 16 h. Slides were washed and stained using Fluidics
Station 450 and antibody amplification staining method according
to the manufacturer’s instructions. Fluorescent signals were
detected by GeneChip Scanner 3000 (Affymetrix).
TaqMan RT-PCR
After microarray gene expression analysis, results were
compared with other data set available in the Gene Expression
Omnibus databank (http://www.ncbi.nlm.nih.gov/geo; series
accession number is GSE18105). TaqMan polymerase chain
reaction was used to measure mRNA expression of 12 selected
genes, participating in regulation of cell cycle, proliferation or
apoptosis, on original (6 histologically intact children, 6 histolog-
ically intact adult and 6 CRC adult samples) and independent sets
of samples (6 histologically intact children, 6 histologically intact
adult, 6 CRC adult samples). 18S ribosomal RNA and GAPDH
were used as reference.
Total RNA extraction, quality and quantity controls were
performed as described earlier. Using the High Capacity cDNA
Reverse Transcription Kit with RNase Inhibitor, 1 mg of total
RNA per sample was reverse transcribed (Life Technologies,
Carlsbad, CA, USA). The quality of cDNA was checked by SDHA
real-time PCR (F. Hoffmann-La Roche Ltd., Basel, Switzerland).
Then 16.7 ng cDNA template per sample was used for expression
analysis of selected genes with TaqMan Gene Expression Master
Table 2. Clinical features of healthy children controls participating in immunohistochemistry, microarray analysis and PCR
validation.
Immunohistochemistry
Patient number Signs/Symptoms Colonoscopy Histology Diagnosis
1. Abdominal pain Negative Negative WD
2. Hematochezia Negative Negative WD
3. Hematochezia Negative Negative Constipation
4. Abdominal pain Negative Negative IBS
5. Hematochezia Negative Negative WD
6. Abdominal pain Negative Negative IBS
7. Abdominal pain Negative Negative IBS
8. Chronic diarrhea Negative Negative IBS
9. Hematochezia Negative Negative WD
10. Chronic diarrhea Negative Negative IBS
11. Chronic diarrhea Negative Negative IBS
12. Hematochezia Negative Negative Constipation
13. Abdominal pain Negative Negative WD
14. Hematochezia Negative Negative Constipation
Affymetrix microarray analysis/Taqman RT-PCR validation - original samples
Patient number Signs/Symptoms Colonoscopy Histology Diagnosis
1. Hematochezia Negative Negative WD
2. Hematochezia Negative Negative WD
3. Abdominal pain Negative Negative WD
4. Vomiting Negative Negative IBS
5. Abdominal pain Negative Negative IBS
6. Abdominal pain Negative Negative WD
Taqman RT-PCR validation - independent samples
Patient number Signs/Symptoms Colonoscopy Histology Diagnosis
1. Hematochezia Negative Negative WD
2. Hematochezia Negative Negative WD
3. Abdominal pain Negative Negative IBS
4. Hematochezia Negative Negative WD
5. Constipation Negative Negative Constipation
6. Hematochezia Negative Negative IBS
WD=Without disease, IBS = Irritable bowel syndrome.
doi:10.1371/journal.pone.0074140.t002
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Mix (Life Technologies). The measurement was carried out on
LightCycler 480 (Roche) with Mono Colour Hydrolysis Probe/
UPL Probe detection format. After denaturation at 95uC for
10 min, 40 PCR cycles were carried out (amplification at 95uC for
15 sec, and at 60uC for 1 min).
Statistical evaluation
For statistical analysis of Ki-67 immunostaining and TUNEL
results the ANOVA test and Tukey HSD post-test were applied. In
both methods significance criteria was p,0.05.
For mRNA expression profiles the Affymetrix expression arrays
were primarily pre-processed by GCRMA background correction
method with quantile normalization and median polish summa-
rization. SAM analysis was applied for determination of prolifer-
ation- and apoptosis-regulating genes with altering mRNA
expression. The following SAM criteria were used: LogFC$abs
1, p-value,0.05. All of these genes were compared and the
differentially expressed ones were further investigated. The
expression of each selected gene among different sample groups
was further analyzed by ANOVA and post-test Tukey HSD.
The datasets are available in the Gene Expression Omnibus
databank (http://www.ncbi.nlm.nih.gov/geo/), series accession
numbers: GSE10714, GSE37364 and GSE37267.
For real-time PCR validation 12 samples were analyzed in each
stage (children, healthy/normal adults and adult CRCs). For
normalization, 18S ribosomal RNA was used as internal control.
For statistical analysis ANOVA test and Tukey HSD post-test
were applied. The following criteria were used: Fold change#0.5
or Fold change$2 and p-value,0.05.
Results
Proliferation and apoptosis in juvenile, normal adult,
adenoma and colorectal carcinoma samples
Proliferating epithelial cells were predominantly localized at
the base of crypts while apoptotic cells were close to the luminal
surface in normal colonic mucosa (Figure 1). Proliferative-
apoptotic ratio (PAR: ratio of proliferative and apoptotic
epithelial cells in crypts) and MI were significantly higher in
children (PAR= 3.5162.49; MI = 0.3360.06) and CRC sam-
ples (PAR= 9.8367.72; MI = 0.4260.10) than in healthy adult
samples (PAR= 0.8860.22; MI = 0.1560.06) (p,0.05). They
showed continuous increase in the course of adenoma-carcino-
ma sequence (ACS). PAR was 3.99 times higher in healthy
children colonic epithelium and 11.17 times higher in CRC as
compared to healthy adult epithelium; and PAR was 2.8 times
higher in CRC in contrast to the juvenile samples. Based on our
immunhistochemical results, MI was 2.2 times higher in
children and 2.8 times higher in CRC compared that to healthy
normal, and 1.27 times higher in CRC in contrast to juvenile
samples. The highest PAR and MI were found in colorectal
cancer samples (Figure 2).
AI was decreased in healthy children samples (0.1360.06) and
significantly lower in colorectal cancer samples (0.0660.03) than
in the histologically intact adult colonic samples (0.1760.05)
(p,0.05). AI showed continuous decrease in parallel with the
colorectal ACS. Apoptotic index was proven 0.76 times lower in
children, and 0.35 times lower in CRC compared to healthy
normal samples; and it was 0.46 times lower in CRC comparing to
juvenile samples. The lowest AI was detected in colorectal cancer
samples (Figure 1–2).
Significant alteration in proliferative activity was not found
between healthy adult colonic mucosa (PAR=0.8860.22;
MI= 0.1560.06) and adenoma samples (PAR=1.4560.89;
MI= 0.1360.05); while the AI was found to be significantly lower
in adenoma samples (Normal AI = 0.1760.05; Adenoma
AI= 0.1060.04) (p,0.05).
Expression of proliferation- and apoptosis-regulating
genes in juvenile, normal adult and colorectal carcinoma
samples
mRNA expression of 117 proliferation-regulating genes were
studied in HGU133 Plus2.0 microarrays. Gene expression of 5
probes (belonging to 4 genes) altered in the course of aging alone
in histologically intact colonic mucosa; mRNA expression of 18
probes (belonging to 13 genes) were altered during colorectal
carcinogenesis; and 11 probes (belonging to 8 genes /BRCA1,
CCNB1, CCNE1, CDC20, CDK1, CDKN2B, MKI67 and
TFDP1/) were differently expressed in both group of samples
(Figure 3A). Similarly, gene expression of 534 apoptosis-regulating
genes was also analyzed in this study. mRNA expression of 15
probes (belonging to 9 genes) altered in the course of aging alone
in histologically intact colonic mucosa; 46 probes (belonging to 32
genes) showed changes during colorectal carcinogenesis; and 12
probes (belonging to 11 genes /ACVR1B, BRCA1, CHEK2,
DYRK2, IFI6, SERPINB9, SFRP1, SOCS3, SST, TNFSF10 and
ZAK/) were differently expressed in both group of samples
(Figure 3B).
Gene expression alterations between juvenile and CRC
samples
Proliferation- and apoptosis-regulating genes were further
investigated to find genes with dissimilar mRNA expression that
can explain the differences between the controlled and uncon-
trolled cellular proliferation. Twelve probes belonging to 8
proliferation-controlling genes (BCL2, CDKN2B, RAD9A,
BRCA2, CCND1, CDK1, CDK6 and RBL1) (Figure 4A) and 26
apoptosis-regulating genes (AIFM2, AIFM3, BTK, CIDEB,
CIDEC, DAPK2, MAL, NLRP1 (LOC728392), SFRP1, SIVA1,
SPN, SST, TR53I3, TNFRSF25, ANXA1, CBX4, CASP4,
INHBA, MYC, PLAGL2, PMAIP1, POLB, PROK2, SOCS3,
TNFRSF10B and ZAK) with 39 probes (Figure 4B) showed
significant alteration between children and cancer groups,
according to the p-value.
Validation of gene expression using TaqMan RT-PCR
mRNA expression of 10 genes including CDKN2B, MKI67,
CDC2/CDK1, CCNE1, ACVR1B, TNFSF10, DYRK2, SOCS3,
IFI6 and SERPINB9 were validated with TaqMan RT-PCR
(Table 3).
According to the results of microarray analysis of proliferation-
regulating genes (CDKN2B, MKI67, CDC2/CDK1 and
CCNE1), significant mRNA expression alterations were detected
by the value of Fold changes (FC#0.5 or FC$2) and the
ANOVA-test (p,0.05) in Children vs. Normal and Normal vs.
CRC comparisons; and these results were also confirmed with
Tukey-test in case of CDC2/CDK1 and CCNE1. PCR validation
confirmed the tendency of gene expression alterations in all cases
with respect to proliferation regulation. CDKN2B, MKI67,
CDC2/CDK1 and CCNE1 showed borderline significant mRNA
expression changes in previously mentioned comparisons, accord-
ing to Fold change. Tukey post-test recruited gene expression
alterations during aging and colorectal carcinogenesis in case of
CDC2/CDK1 (p,0.05).
Numbers of apoptosis-regulating genes (ACVR1B, TNFSF10,
DYRK2, SOCS3, IFI6 and SERPINB9) were also analyzed with
RT-PCR. Gene expression of ACVR1B, TNFSF10 and DYRK2
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was significantly lower in children and CRC samples compared
to normal adult colonic mucosa (FC#0.5 or FC$2; p,0.05);
and these results were validated by RT-PCR as well. According
to the results of Affymetrix study, mRNA expression of anti-
apoptotic genes, such as SOCS3, IFI6 and SERPINB9, showed
significantly higher expression in children and CRC samples as
compared that to histologically intact adult colonic samples.
PCR validation confirmed the tendency of gene expression
alterations between Children vs. Adult Normal and Adult
Normal vs. CRC. ANOVA and Tukey-test analysis of RT-PCR
results have verified these alterations in case of SOCS3 and IFI6
(p,0.05). Expression changes of the selected genes are
summarized in Table 4.
Discussion
Aging is associated with increased incidence of sporadic
colorectal malignancies, which is one of the leading causes of
mortality in Western countries [33]. Colorectal cancer is related to
uncontrolled cellular proliferation and dysregulated apoptosis.
Juvenile growth, on the other hand, is characterized by controlled
growth, cellular proliferation and apoptosis [34].
In this study the proliferative and apoptotic activity in intact
human colorectal epithelium from children and adults compared
to that in adenoma and colorectal cancer was investigated.
Expression of the related genes was also tested in mRNA
microarrays. We found an increased proliferative and a decreased
Figure 1. Detection of proliferative (red nuclei) and apoptotic (green nuclei) cells during aging and colorectal adenoma-carcinoma
sequence (ACS) with fluorescent staining. Blue spots represent the nuclei of inactive cells. Images were taken with digital microscope: normal
child tissue (Ch), normal adult tissue (N), adenoma (Ad) and carcinoma (CRC) in adult. Mitotic activity decreases during aging and increases during the
ACS in contrast to apoptotic activity.
doi:10.1371/journal.pone.0074140.g001
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apoptotic activity in children and cancer samples compared to
normal adult epithelium.
These results suggest an opposing molecular regulation of
proliferation and apoptosis during normal aging and colorectal
carcinogenesis. Enhanced cellular proliferation of tumor cells
without ‘‘aging’’ can contribute to their survival advantage over
adjacent senescent cells.
An increased cellular proliferation detected in children colorec-
tal mucosa can be related to the physiologic growth of the large
bowel however, the cell renewal slows down during normal aging
in the histologically intact adult colonic crypt. Cell proliferation
and apoptosis regulation between controlled growth in childhood
and uncontrolled growth in CRC have not been correlated before
in the colonic mucosa. Here we found several proliferation
promoting genes including cyclin B1 /CCNB1/, cyclin E1 /
CCNE1/ and cyclin-dependent kinase (CDK1) to be upregulated
both in young and cancer samples compared to normal adult
mucosa (Figure 3). These results correlate well with our finding
significantly higher proliferating cell fractions in children and
cancer tissue sections compared to normal adult samples. CDKs,
indeed, have crucial role in the regulation of cell-cycle and growth
in eukaryotic cells. CDK complexes are a highly conserved family
of Ser/Thr protein kinases, consisting of a catalytic CDK subunit
and an activating cyclin subunit. Different CDKs can control
different parts of the cell-cycle; these complexes can be activated
by phosphorylation, binding activating cyclins or inhibiting
subunits [35–36]. CCNB1, CCNE1 and CDK1 expressions,
which can correlate to an increased proliferative activity, were
higher in children and neoplastic colonic mucosa compared to
normal adult mucosa. Furthermore, cyclin D1 (CCND1), CDK1
and CDK6 mRNA levels were significantly higher in CRC
compared to normal children samples, which may be related to
the uncontrolled cellular proliferation in cancer (Figure 4). Cyclin
D1 has several regulatory effects in normal cellular differentiation,
Figure 2. Alterations of proliferative-apoptotic ratio /PAR/ (A), mitotic index /MI/ (B) and apoptotic index /AI/ (C) during aging in
histologically intact colonic mucosa and in ACS. PAR and MI decrease during aging and increase during carcinogenesis, contrary to AI.
doi:10.1371/journal.pone.0074140.g002
Figure 3. Changes in mRNA expression of proliferation- (A) and apoptosis-regulating genes (B) during aging (Children /Ch/ vs.
Healthy adult /N/ colonic epithelium) and carcinogenesis (Healthy adult /N/ vs. Colorectal cancer /CRC/) using Affymetrix HGU133
Plus2.0 array. On the heat map, increased gene expression is represented with red lines, while decreased expression with green. The first 6 samples
with light blue show genes in children, the dark blue are from healthy adults, while the last samples in green are from cancer patients.
doi:10.1371/journal.pone.0074140.g003
Rejuvenescence-Like Cell Growth in Sporadic CRC
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e74140
growth and metabolism; however, the overexpression of CCND1
is one of the most commonly observed alteration in human
cancers, as it has cell-cycle regulatory effects in G1 phase [37].
According to Zhang et al. results, the abnormal up-regulation of
cyclin D1 can be an early event in intestinal carcinogenesis [38].
Sahl et al. have investigated the expression of different cyclin-
dependent kinases in human colon cancer. They observed that the
activation of CDK1, CDK2 and CDK6, which can phosphorylate
the retinoblastoma protein, resulting in the release from the
inhibition of forward progression of the G1 phase, is in connection
with human colorectal carcinogenesis [39].
There are several regulatory molecules that can modulate and
block the function of CKDs, called cyclin-dependent kinase
inhibitors. In our present study, we investigated the mRNA
expression alterations of CDKN2B in the processes of aging and
colorectal carcinogenesis. CDKN2B is also known as multiple
tumor suppressor 2 (MTS2), cyclin-dependent kinases 4 and 6
binding protein or p15-INK4b (p15). CDKN2B is located
adjacent to tumor suppressor CDKN2A in the chromosome 9,
which is frequently mutated and deleted in a wide variety of
neoplasms. This gene encodes a cyclin-dependent kinase inhibitor
that can produce complexes with CDK4 and CDK6, inhibiting
the cellular growth or cell-cycle. In microarray analysis a moderate
mRNA expression of CDKN2B was found in well-controlled,
hyper-proliferative colonic biopsy samples from children as
compared to histologically intact adult colonic mucosa, and a
remarkable gene expression reduction was observed in CRC
samples (Figure 3). According to previous studies, CDKN2B may
act as a tumor suppressor gene and a potential effector of TGFb-
induced cell-cycle arrest [40]. Herman et al. certified that gene
Figure 4. Proliferation (A) and apoptosis (B) controlling genes, that showed significant mRNA expression alterations between
healthy young (Ch) and colorectal cancer (CRC) samples. On the heat map, increased gene expression is represented with red lines, while
decreased expression with green. The dark blue samples are from healthy children colonic mucosa (Ch) and the light blue are from colorectal cancer
samples (CRC).
doi:10.1371/journal.pone.0074140.g004
Table 3. Cell proliferation- and apoptosis-regulating genes analyzed in the study.
Gene symbol Affymetrix ID Taqman ID Gene name Gene function
CDKN2B 236313_at Hs00365249_m1* Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) Negative regulation of (epithelial) cell
proliferation.
MKI67 212022_s_at Hs01032443_m1* Antigen identified by monoclonal antibody Ki-67 Cell proliferation/cell cycle regulation.
CDC2/CDK1 210559_s_at Hs00364293_m1 Cell division cycle 2, G1 to S and G2 to M Cell cycle and cell division regulation.
Anti-apoptosis.
CCNE1 213523_at Hs01026536_m1* Cyclin E1 Cell cycle and cell division regulation.
Organ development and regeneration.
ACVR1B 208223_s_at Hs00923304_m1 Activin A receptor, type IB Induction of apoptosis.
TNFSF10 214329_x_at Hs00234356_m1* Tumor necrosis factor (ligand) superfamily, member 10 Induction of apoptosis.
DYRK2 202971_s_at Hs00705109_s1* Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 Induction of apoptosis.
SOCS3 227697_at Hs02330328_s1* Suppressor of cytokine signaling 3 Anti-apoptosis. Regulation of growth.
Response to hypoxia. Aging.
IFI6 204415_at Hs00242571_m1* Interferon, alpha-inducible protein 6 Anti-apoptosis.
SERPINB9 242814_at Hs00244603_m1* Serpin peptidase inhibitor, clade B (ovalbumin), member 9 Anti-apoptosis.
doi:10.1371/journal.pone.0074140.t003
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silencing of p15 by CpG island hypermethylation can cause
neoplastic disorders [41]. Significant loss of these genes’ functions
may contribute to the uncontrolled cellular proliferation in CRC.
In immunohistochemical analysis, a moderately decreased
apoptotic activity was found in healthy children colorectal biopsy
samples compared to healthy adults and it was dramatically
reduced in the course of adenoma-carcinoma sequence. mRNA
expression alterations of apoptosis-inducing or -inhibiting genes
analyzed in our study (e.g. ACVR1B, TNFSF10, DYRK2,
SOCS3, IFI6 and SERPINB9) may explain this phenomenon.
Since we observed a similarity of cellular proliferation and
apoptosis tendency in healthy children and colorectal cancer, we
tried to find a molecular discrepancy between the controlled and
uncontrolled epithelial renewal.
At the mRNA level, significantly decreased somatostatin (SST)
production was detected in CRC compared to that in healthy
colonic biopsy samples from children; however, only a moderate
decline in somatostatin expression in healthy adults was noted.
SST is mainly secreted in the central nervous system; but its local
secretion in the gastrointestinal tract is also well-documented. It
has endocrine, paracrine effects; and through SST receptors, it
directly exerts cell-cycle arrest and induces apoptosis [42]. After
microarray analysis, we validated this observation on both
dependent and independent sets of samples by using RT-PCR.
According to our preliminary results we could presume that the
local absence of SST production may contribute to the uncon-
trolled cellular proliferation in CRC.
We have analyzed and compared the proliferative and apoptotic
activity in normal children, adult and CRC samples and tried to
find the mRNA expression alterations in the background of
controlled cellular proliferation in children and uncontrolled
cellular proliferation in CRC. According to our immunohisto-
chemical results, it has to be mentioned that cellular proliferation
significantly decreases during physiological aging in histologically
intact colorectal epithelium; moreover, the proliferative activity
does not differ in normal adult and adenoma samples. However,
the apoptotic activity is significantly lower in adenoma samples as
compared that to normal adult samples. Thus, we can assume that
a decreased apoptosis has a major role in the misbalanced cell-
renewal and cell-death of the adenomatous status. In colorectal
cancer, both of the increased cellular proliferation and nearly
absent apoptosis may contribute to the uncontrolled cellular
growth.
As we are aware, this is the first study to investigate mRNA
expression in children colorectal biopsy samples with particular
focus on proliferation and apoptosis regulation. Furthermore,
these results were correlated with in situ mitosis and apoptosis
index in comparison with those of normal adult samples and
colorectal cancer. The lack of similar data prevented us to
compare ours with other data sets on Gene Expression Omnibus
databank. Since routine colonoscopy in children is rarely
performed, collection from children colonic samples was the
bottleneck of this study. In most children biopsies available for us
other intestinal disorder e.g. inflammatory bowel disease, was
Table 4. Averages and standard deviation of normalized log2 intensities on microarray and RT-PCR, with ANOVA analysis.
Gene symbol Affymetrix ID
Averages and standard deviations of normalized log2 intensities on
microarrays ANOVA on microarray
Children (Ch) Healthy adults (N) CRCs (CRC)
CDKN2B 236313_at 10.1360.45 11.6460.61 7.7462.55 2.90E-14
MKI67 212022_s_at 9.0260.95 7.9460.78 9.9761.35 3.67E-11
CDC2/CDK1 210559_s_at 8.7360.65 7.6160.69 9.4661.45 1.09E-09
CCNE1 213523_at 6.8960.39 5.7160.4 6.7460.84 4.96E-10
ACVR1B 208223_s_at 4.7560.65 5.7960.8 4.7261.09 1.08E-05
TNFSF10 214329_x_at 9.8760.47 10.9760.52 9.8960.88 6.05E-09
DYRK2 202971_s_at 10.2760.37 11.3960.58 10.2460.78 2.12E-10
SOCS3 227697_at 8.261.04 6.4461.21 10.2761.86 2.20E-16
IFI6 204415_at 7.0761.66 5.9260.95 7.9761.49 4.18E-09
SERPINB9 242814_at 5.4361.36 4.360.78 5.3961.82 2.20E-03
Gene symbol Taqman ID Averages and standard deviations of normalized intensities in RT-PCR ANOVA on RT-PCR
Children (Ch) Healthy adults (N) CRCs (CRC)
CDKN2B Hs00365249_m1* 14.1360.37 14.3760.22 13.9660.44 2.19E-01
MKI67 Hs01032443_m1* 22.9460.51 22.2460.58 22.6360.55 1.10E-01
CDC2/CDK1 Hs00364293_m1 19.7360.6 18.560.82 19.8361.1 4.99E-03
CCNE1 Hs01026536_m1* 20.0160.41 19.4360.51 19.9860.8 7.05E-02
ACVR1B Hs00923304_m1 15.560.93 15.4561.02 16.0862.52 4.90E-01
TNFSF10 Hs00234356_m1* 22.460.26 23.2260.22 22.5560.77 3.22E-03
DYRK2 Hs00705109_s1* 22.8260.3 23.3160.37 22.6660.67 8.24E-03
SOCS3 Hs02330328_s1* 21.8561.09 20.2960.55 22.7261.41 1.90E-04
IFI6 Hs00242571_m1* 21.3561.38 20.4260.52 22.3761.23 8.94E-05
SERPINB9 Hs00244603_m1* 20.5760.47 2060.42 20.6160.75 2.30E-01
P-values of ANOVA analysis on microarray and RT-PCR represents in the last column. The significant different expression (p,0.05) is marked in bold.
doi:10.1371/journal.pone.0074140.t004
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diagnosed, which restricted our selection for only a few cases. This
can explain both the lack of databank data and the relatively low
number of such samples in our study.
In summary, we tested the proliferation- and apoptosis-related
gene expression along with mitotic and apoptotic index in
colorectal epithelium in the course of normal aging and colorectal
carcinogenesis. We found similarly elevated proliferative and
decreased apoptotic activities both in histologically intact children
colonic mucosa and CRC samples compared to healthy adult
samples, where cancer showed the significantly largest cell kinetic
alterations. Physiological growth and development may result in
an increased and controlled proliferative activity in children’s
colorectal epithelium which is a well-balanced process compared
to the uncontrolled cellular proliferation in CRC. The distinct
gene expression profiles between juvenile and cancer growth are
likely to be regulated by genetic and epigenetic alterations.
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